Antimicrobial Resistance of Streptococcus uberis Isolated from Bovine Mastitis: A Review

Abstract

Bovine mastitis is one of the common diseases resulting in high economic losses in the dairy industry. Streptococcus uberis, the environmental or contagious pathogen, is one of the most frequently identified bacteria causing clinical and subclinical mastitis. Antimicrobials are commonly used to control bacterial infections in dairy cattle. The emergence of antimicrobial resistance (AMR) bacteria made the treatment of this disease by antimicrobials a challenge. Currently, AMR is a global threat to both human and animal health. This review summarizes the AMR profiles of S. uberis collected worldwide between the years 2000-2020. Most of the studies included in this review were from Europe, Estonia, Canada, Danish, Switzerland and Czech. In general, S. uberis is highly susceptible to β-lactam antimicrobials, whereas resistance to tetracyclines, macrolides, aminoglycosides antimicrobials occurred in most countries. The isolates against most antimicrobials presented an increasing pattern over time. It highlights that monitoring the AMR of S. uberis is crucial to reduce the public health crisis.

Biofilm Formation and Antimicrobial Resistance of Staphylococcus aureus and Streptococcus uberis Isolates from Bovine Mastitis

“…uberis exhibited substantial resistance to oxacillin (80.6%), penicillin (80.6%), tetracycline (37.8%), and pirlimycin (14.2%). This is consistent with varying reports in different regions, which showed high resistance rates to oxacillin in Switzerland (64.7%) and Korea (33.3%) [42]. The resistance rates to tetracycline differed notably, ranging from 27.1% to our finding of 37.8% [43].…”